Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262)

製品コード：A2604         Batch: A260401

印刷

Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). It induces cell apoptosis of cancer cells and inhibits tumor growth and can be used for the research of cancer. MW :150 KD.

製品説明

CAS No. 918127-53-4
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 12.43mg/ml
Endotoxin Level ＜1EU/mg

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

pH and TRAIL receptors interplay in pancreatic ductal adenocarcinoma cells [ Inaugural dissertation for obtaining the doctoral degree of the Combined Faculty of Mathematics, Engineering and Natural Science, Christian-Albrechts , 2022, 31]

人間や獣医の診断であるか治療的な使用のためにでない。